Disorder-specific changes in innervation in oral lichen planus and lichenoid reactions

Journal of Oral Pathology and Medicine

Volumn 29, Issue 8, 2000, Pages 361-369

  Niissalo, Sirkku ^a   Hietanen, Jarkko ^a   Malmström, Maria ^a   Hukkanen, Mika ^b   Polak, Julia ^b   Konttinen, Yrjö T ^c,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF HELSINKI   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Innervation; Lichen planus; Neurogenic inflammation; Neuropeptides

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NERVE PROTEIN; NEUROPEPTIDE Y; SUBSTANCE P; THIOL ESTER HYDROLASE; UBIQUITIN THIOLESTERASE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADRENERGIC SYSTEM; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BASEMENT MEMBRANE; CHRONIC DISEASE; COMPARATIVE STUDY; HUMAN; INNERVATION; LICHEN PLANUS; LICHENOID ERUPTION; MIDDLE AGED; MOUTH DISEASE; MOUTH MUCOSA; NERVE FIBER; NONPARAMETRIC TEST; PATHOLOGY; STOMATITIS;

ADULT; AGED; ANALYSIS OF VARIANCE; BASEMENT MEMBRANE; CALCITONIN GENE-RELATED PEPTIDE; CHRONIC DISEASE; HUMANS; LICHEN PLANUS, ORAL; LICHENOID ERUPTIONS; MIDDLE AGED; MOUTH DISEASES; MOUTH MUCOSA; NERVE FIBERS; NERVE TISSUE PROTEINS; NEUROPEPTIDE Y; STATISTICS, NONPARAMETRIC; STOMATITIS; SUBSTANCE P; SYMPATHETIC NERVOUS SYSTEM; THIOLESTER HYDROLASES; UBIQUITIN THIOLESTERASE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0033846475     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2000.290801.x     Document Type: Article

References (50)

1. Jungell P. Oral lichen planus. A review. Int J Oral Maxillofac Surg 1991; 20: 129-35.
2. Scully C, El-Kom M. Lichen planus: review and update on pathogenesis. J Oral Pathol 1985; 14: 431-58.
3. McCartan BE, McCreary CE. Oral lichenoid drug eruptions. Oral Dis 1997; 3: 56-63.
4. Anonymous. Third European Congress of Oral Medicine. Oral Dis 1997; 3: 43-8.
5. Histological typing of cancer and precancer of the oral mucosa. In: Pindborg JJ, Reichart PA, Smith CJ, van der Waal I, eds. WHO international histological classification of tumours. Berlin: Springer-Verlag, 1997; 30.
6. Lacy MF, Reade PC, Hay KD. Lichen planus: a theory of pathogenesis. Oral Surg Oral Med Oral Pathol 1983; 11: 521-6.
7. Porter SR, Kirby A, Olsen I, Barrett W. Immunologic aspects of dermal and oral lichen planus. A review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83: 358-66.
8. Walsh LJ, Savage NW, Ishii T, Seymour GJ. Immunopathogenesis of oral lichen planus. J Oral Pathol Med 1990; 19: 389-96.
9. Barnes PJ, Belvisi MG, Rogers DF. Modulation of neurogenic inflammation: novel approaches to inflammatory disease. Trends Pharmacol Sci 1990; 11: 185-9.
10. Donnerer J, Stein C. Evidence for an increase in the release of CGRP from sensory nerves during inflammation. Ann NY Acad Sci 1992; 657: 505-6.
11. Foreman JC. Peptides and neurogenic inflammation. Br Med Bull 1987; 43: 386-400.
12. Jänig W, Levine JD, Michaelis M. Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma. In: Kumazawa T, Kruger L, Mizumura K, eds. Progress in brain research. Amsterdam: Elsevier Science BV, 1996; 113: 161-84.
13. Konttinen YT, Kemppinen P, Segerberg M, et al. Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis Rheum 1994; 37: 965-82.
14. Pincelli C, Fantini F, Giannetti A. Neuropeptides and skin inflammation. Dermatology 1993; 187: 153-8.
15. Sirinek LP, O'Dorisio MS. Modulation of immune function by intestinal neuropeptides. Acta Oncol 1991; 30: 509-17.
16. Weihe E, Nohr D, Müller S, Büchler M, Friess H, Zentel HJ. The tachykinin neuroimmune connection in inflammatory pain. Ann NY Acad Sci 1991; 632: 283-95.
17. Imai S, Tokunaga Y, Konttinen YT, Maeda T, Hukuda S, Santavirta S. Ultrastructure of the synovial sensory peptidergic fibers is distinctively altered in different phases of adjuvant induced arthritis in rats: ultramorphological characterization combined with morphometric and immunohistochemical study for substance P, calcitonin gene related peptide, and protein gene product 9.5. J Rheumatol 1997; 24: 2177-87.
18. Konttinen YT, Rees R, Hukkanen M, et al. Nerves in inflammatory synovium. Immunohistochemical observations on the adjuvant arthritic rat model. J Rheumatol 1990; 17: 1586-91.
19. Mapp PI, Kidd BL, Gibson SJ, et al. Substance P-, calcitonin gene-related peptide and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience 1990; 37: 143-53.
20. Weihe E, Nohr D, Millan MJ, et al. Peptide neuroanatomy of adjuvant-induced arthritic inflammation in rat. Agents Actions 1988; 25: 255-9.
21. Terenghi G, Zhang SQ, Unger WG, Polak JM. Morphological changes of sensory CGRP-immunoreactive and sympathetic nerves in peripheral tissues following chronic denervation. Histochemistry 1986; 86: 89-95.
22. Ansel JC, Kaynard AH, Armstrong CA, Olerud J, Bunnett N, Payan D. Skin-nervous system interactions. J Invest Dermatol. 1996; 106: 198-204.
23. Stanisz AM, Scicchitano R, Bienenstock J. The role of vasoactive intestinal peptide and other neuropeptides in the regulation of the immune response in vitro and in vivo. Ann NY Acad Sci 1988; 527: 478-85.
24. Manyth PW. Substance P and the inflammatory and immune response. Ann NY Acad Sci 1991; 632: 263-71.
25. Hermanson A, Dalsgaard CJ, Björklund H, Lindblom U. Sensory reinnervation and sensibility after superficial skin wounds in human patients. Neurosci Lett 1987; 74: 377-82.
26. Kinnman E, Aldskogius H, Wiesenfeld-Hallin Z, Johansson O. Expansion of sensory innervation after peripheral nerve injury. In: Bond MR, Charlton JE, Woolf CJ, eds. Proceedings of the VIth world congress on pain. Seattle: Elsevier Science Publishers BV, 1991: 277-81.
27. Raud J, Lundeberg T, Brodda-Jansen G, Theodorsson E, Hedqvist P. Potent anti-inflammatory action of calcitonin gene-related peptide. Biochem Biophys Res Commun 1991; 180: 1429-35.
28. Anad P. Nerve growth factor regulates nociception in human health and disease. Br J Anaest 1995; 75: 201-8.
29. Brain SD, Cambridge H, Hughes SR, Wilsoncroft P. Evidence that calcitonin gene-related peptide contributes to inflammation in the skin and joint. Ann NY Acad Sci 1992; 657: 412-9.
30. Walsh DA, Wharton J, Blake DR, Polak JM. Neural and endothelial regulatory peptides, their possible involvement in inflammation. Int J Tiss React XIV, 1992; 3: 101-11.
31. Törnwall J, Uusitalo H, Hukkanen M, Sorsa T, Konttinen YT. Distribution of vasoactive intestinal peptide (VIP) and its binding sites in labial salivary glands in Sjögren's syndrome and in normal controls. Clin Exp Rheumatol 1994; 12: 287-92.
32. Konttinen YT, Sorsa T, Hukkanen M, et al. Topology of innervation of labial salivary glands by protein gene product 9.5 and synaptophysin immunoreactive nerves in patients with Sjögren's syndrome. J Rheumatol 1992; 19: 30-7.
33. Kidd BL, Mapp PI, Gibson SJ, et al. A neurogenic mechanism for symmetrical arthritis. Lancet 1989; 11: 1128-30.
34. Levine JD, Collier DH, Basbaum AI, Moskowitz MA, Helms CA. Hypothesis: the nervous system may contribute to the pathophysiology of rheumatoid arthritis. J Rheumatol 1985; 12: 406-11.
35. Eedy DJ, Johnston CF, Shaw C, Buchanan KD. Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. J Invest Dermatol 1991; 96: 434-8.
36. Farber EM, Nickoloff BJ, Recht B, Fraki JE. Stress, symmetry and psoriasis: possible role of neuropeptides. J Am Acad Dermatol 1986; 98: 616-40.
37. Konttinen YT, Häyrinen-Immonen RH, Nordström D, et al. Innervation of recurrent aphthous ulcers. Oral Microbiol Immunol 1994; 9: 60-4.
38. Zhao ZZ, Savage NW, Pujic Z, Walsh LJ. Immunohistochemical localization of mast cells and mast cell-nerve interactions in oral lichen planus. Oral Dis 1997; 3: 71-6.
39. Allen CM, Beck FM, Rossie KM, Kaul TJ. Relation of stress and anxiety to oral lichen planus. Oral Surg Oral Med Oral Pathol 1986; 61: 44-6.
40. Rojo-Moreno JL, Bagan JV, Rojo-Moreno J, Donat JS, Milian MA, Jimenez Y. Psychologic factors and oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 687-91.
41. Ottaway CA. Vasoactive intestinal peptide as a modulator of lymphocyte and immune function. Ann NY Acad Sci 1988; 527: 486-500.
42. Merighi A, Polak JM, Gibson SJ, Gulbenkian S. Ultrastructural studies on calcitonin gene-related peptide-, tachykinins-and somatostatin-immunoreactive neurones in rat dorsal root ganglia: evidece for the colocalization of different peptides in single secretory granules. Cell Tissue Res 1988; 254: 101-9.
43. Shu S, Ju G, Fan L. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of nervous system. Neurosci Lett 1988; 85: 169-71.
44. Ruokonen H, Hietanen J, Malmström M, et al. Peripheral nerves and mast cells in normal buccal mucosa. J Oral Pathol Med 1993; 22: 30-4.
45. Jungell P. Immunoelectronic microscopic study of basement membrane in oral lichen planus. J Cutan Pathol 1987; 16: 170-8.
46. Dalsgaard CJ, Hultgårdh-Nilsson A, Haegerstrand A, Nilsson J. Neuropeptides as growth factors. Possible roles in human diseases. Regul Pept 1989; 25: 1-9.
47. Miles K, Chelmicka-Schorr E, Atweh S, Otten G, Arnason BGW. Sympathetic ablation alters lymphocyte membrane properties. J Immunol 1985; 135: 797s-801s.
48. O'Dorisio MS, Wood CL, O'Dorisio TM. Vasoactive intestinal peptide and neuropeptide modulation of the immune response. J Immunol 1985; 135: 792s-6s.
49. Jungell P, Konttinen YT, Nortamo P, Malmström M. Immunoelectron microscopic study of distribution of T cell subsets in oral lichen planus. Scand J Dent Res 1989; 97: 361-7.
50. Allen JM, Polak JM, Bloom SR. Presence of the predicted C-flanking peptide of neuropeptide Y (CPON) in tissue extracts. Neuropeptides 1985; 6: 95-100.